These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9925182)

  • 1. Divided attention in major depression.
    Thomas P; Goudemand M; Rousseaux M
    Psychiatry Res; 1998 Dec; 81(3):309-22. PubMed ID: 9925182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attentional resources in major depression.
    Thomas P; Goudemand M; Rousseaux M
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(2):79-85. PubMed ID: 10369154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone.
    Ferreri M; Lavergne F; Berlin I; Payan C; Puech AJ
    Acta Psychiatr Scand; 2001 Jan; 103(1):66-72. PubMed ID: 11202131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
    Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L
    Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative magnetic resonance imaging study of caudate and lenticular nucleus gray matter volume in primary unipolar major depression: relationship to treatment response and clinical severity.
    Pillay SS; Renshaw PF; Bonello CM; Lafer BC; Fava M; Yurgelun-Todd D
    Psychiatry Res; 1998 Dec; 84(2-3):61-74. PubMed ID: 10710164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of symptom improvement during antidepressant treatment of delusional depression.
    Serretti A; Lattuada E; Zanardi R; Franchini L; Smeraldi E
    Psychiatry Res; 2000 May; 94(2):185-90. PubMed ID: 10808044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of clinical variables, neuropsychological performance and SLC6A4 and COMT gene polymorphisms on the prediction of early response to fluoxetine in major depressive disorder.
    Gudayol-Ferré E; Herrera-Guzmán I; Camarena B; Cortés-Penagos C; Herrera-Abarca JE; Martínez-Medina P; Cruz D; Hernández S; Genis A; Carrillo-Guerrero MY; Avilés Reyes R; Guàrdia-Olmos J
    J Affect Disord; 2010 Dec; 127(1-3):343-51. PubMed ID: 20584552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse.
    Iovieno N; van Nieuwenhuizen A; Clain A; Baer L; Nierenberg AA
    Depress Anxiety; 2011 Feb; 28(2):137-44. PubMed ID: 21284066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fluoxetine versus fluvoxamine for treatment of chronic pain].
    Ciaramella A; Grosso S; Poli P
    Minerva Anestesiol; 2000; 66(1-2):55-61. PubMed ID: 10736983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automatic and effortful information processing in unipolar major depression.
    Hammar A
    Scand J Psychol; 2003 Dec; 44(5):409-13. PubMed ID: 15030106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment.
    Mauri MC; Ferrara A; Boscati L; Bravin S; Zamberlan F; Alecci M; Invernizzi G
    Neuropsychobiology; 1998; 37(3):124-9. PubMed ID: 9597668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.
    Otsubo T; Akimoto Y; Yamada H; Koda R; Aoyama H; Tanaka K; Mimura M; Nakagome K; Kamijima K
    Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression.
    Dam J; Ryde L; Svejsø J; Lauge N; Lauritsen B; Bech P
    Pharmacopsychiatry; 1998 Mar; 31(2):48-54. PubMed ID: 9562208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognition in depression: patients on and off medication versus healthy comparison subjects.
    Gualtieri CT; Johnson LG; Benedict KB
    J Neuropsychiatry Clin Neurosci; 2006; 18(2):217-25. PubMed ID: 16720799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired flexible decision-making in Major Depressive Disorder.
    Cella M; Dymond S; Cooper A
    J Affect Disord; 2010 Jul; 124(1-2):207-10. PubMed ID: 20004023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early improvements in anxiety, depression, and anger/hostility symptoms and response to antidepressant treatment.
    Farabaugh A; Sonawalla S; Johnson DP; Witte J; Papakostas GI; Goodness T; Clain A; Baer L; Mischoulon D; Fava M; Harley R
    Ann Clin Psychiatry; 2010 Aug; 22(3):166-71. PubMed ID: 20680189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retardation in depression: assessment by means of simple motor tasks.
    Sabbe B; Hulstijn W; van Hoof J; Tuynman-Qua HG; Zitman F
    J Affect Disord; 1999 Sep; 55(1):39-44. PubMed ID: 10512604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of antidepressant response to fluvoxamine obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale for major depressive disorders in Japanese patients.
    Higuchi H; Sato K; Yoshida K; Takahashi H; Kamata M; Otani K; Yamaguchi N
    Psychiatry Clin Neurosci; 2008 Jun; 62(3):301-6. PubMed ID: 18588590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psychomotor retardation in depression assessed by visuomotor tasks. Overview and achievements of ten years' research].
    Pier MP; Hulstijn W; van Hoof JJ; Sabbe BG
    Tijdschr Psychiatr; 2006; 48(2):95-106. PubMed ID: 16958193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.